Depressive symptoms and cognitive decline: A longitudinal analysis of potentially modifiable risk factors in community dwelling older adults

被引:60
作者
Gallagher, Damien [1 ,2 ]
Kiss, Alex [3 ,4 ]
Lanctot, Krista [3 ,5 ,6 ,7 ]
Herrmann, Nathan [1 ,2 ]
机构
[1] Sunnybrook Hlth Sci Ctr, Div Geriatr Psychiat, Toronto, ON M4N 3M5, Canada
[2] Univ Toronto, Toronto, ON M5S 1A1, Canada
[3] Univ Toronto, Sunnybrook Res Inst, Toronto, ON M5S 1A1, Canada
[4] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada
[5] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada
[6] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A1, Canada
[7] Univ Toronto, Dept Toxicol, Toronto, ON M5S 1A1, Canada
关键词
Depression; Older age; Inflammation; Cognition; Physical activity; Vascular risk factors; ALZHEIMERS-DISEASE; NEUROTROPHIC FACTOR; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; DEMENTIA; INFLAMMATION; METAANALYSIS; IMPAIRMENT; EXERCISE; INCREASE;
D O I
10.1016/j.jad.2015.09.046
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Depressive symptoms have been associated with increased risk of cognitive decline in later life. There are no interventions proven to reduce risk of cognitive decline in older adults with depression, and it is unclear how these effects are mediated. We aim to determine what mediates the relationship between depressive symptoms and cognitive decline in later life. Methods: Seven thousand six hundred and sixty six community dwelling older adults (age >= 50) from the English Longitudinal study of Ageing (ELSA) underwent clinical assessment. Inflammation was assessed with C Reactive Protein and depressive symptoms were assessed with the 8-item version of the Center for Epidemiologic Studies (CESD) scale. Results: Five thousand, five hundred and ninety (73.5%) had a follow-up cognitive assessment after a median of 47 months. Depressive symptoms were independently associated with cognitive decline (B=0.09, p < 0.001). Low physical activity, inflammation, metabolic syndrome and vascular risk factors were associated with elevated depressive symptoms. Low physical activity (z=2.16, p=0.03) and inflammation (z=2.3, p=0.02) mediated the relationship between depressive symptoms and cognitive decline while hypertension, diabetes and smoking also contributed. Limitations: This is an observational study with a limited duration of follow up. Not all variables related to cognitive decline were accounted for in this analysis. Conclusions: The relationship between depressive symptoms and cognitive decline in later life appears to be mediated by low physical activity, increased inflammation and vascular risk factors that may be amenable to modification. (C) 2015 Published by Elsevier B.V.
引用
收藏
页码:235 / 240
页数:6
相关论文
共 48 条
[1]  
Alberti K.G. M. M., 2006, METABOLIC SYNDROME N
[2]   Executive dysfunction and the course of geriatric depression [J].
Alexopoulos, GS ;
Kiosses, DN ;
Heo, M ;
Murphy, CF ;
Shanmugham, B ;
Gunning-Dixon, F .
BIOLOGICAL PSYCHIATRY, 2005, 58 (03) :204-210
[3]  
Allied Dunbar National Fitness Survey, 1992, MAIN FIND ACT HLTH R
[4]  
[Anonymous], 2012, FINANCIAL CIRCUMSTAN
[5]  
[Anonymous], 1982, SOCIOL METHODOL
[6]   The projected effect of risk factor reduction on Alzheimer's disease prevalence [J].
Barnes, Deborah E. ;
Yaffe, Kristine .
LANCET NEUROLOGY, 2011, 10 (09) :819-828
[7]   THE MODERATOR MEDIATOR VARIABLE DISTINCTION IN SOCIAL PSYCHOLOGICAL-RESEARCH - CONCEPTUAL, STRATEGIC, AND STATISTICAL CONSIDERATIONS [J].
BARON, RM ;
KENNY, DA .
JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY, 1986, 51 (06) :1173-1182
[8]  
Becker E., 2006, Health Surv Engl, P34
[9]   Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): Results from a community-based sample of older subjects in the Netherlands [J].
Beekman, ATF ;
Deeg, DJH ;
VanLimbeek, J ;
Braam, AW ;
DeVries, MZ ;
VanTilburg, W .
PSYCHOLOGICAL MEDICINE, 1997, 27 (01) :231-235
[10]   Longitudinal Inflammation, Cognitive Decline, and Alzheimer's Disease: A Mini-Review [J].
Bettcher, B. M. ;
Kramer, J. H. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (04) :464-469